GlassScriptPhysician profile
E Jason Gates
NPI 1821075151
$2,543.50
in general payments reported to CMS, 2019-2025
21 companies · $62.96 in 2025
The $62.96 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $272 · 2021: $541 · 2022: $237 · 2023: $348 · 2024: $492 · 2025: $62.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809 · Gift: $93.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.82 |
| Gift | $93.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $669.22 | 2019-2025 | Da Vinci Surgical System |
| Clovis Oncology, INC. | $333.44 | 2019-2020 | |
| Pfizer INC. | $198.16 | 2024-2025 | |
| Abbvie INC. | $143.59 | 2020-2024 | |
| Seagen INC. | $138.60 | 2021-2023 | Tivdak |
| Biom'Up France Sas | $126.29 | 2021 | |
| Stryker Corporation | $125.42 | 2019 | |
| Merck Sharp & Dohme LLC | $121.37 | 2019-2024 | Lynparza |
| Astrazeneca Pharmaceuticals LP | $105.19 | 2019-2020 | |
| Tempus Ai, INC | $104.20 | 2024 | Xt Cdx |
| Glaxosmithkline, LLC. | $99.90 | 2021 | |
| Smith+Nephew, INC. | $60.28 | 2022 | |
| Tesaro, INC. | $54.49 | 2019 | |
| Dysis Medical, INC. | $50.89 | 2019 | |
| Ethicon US, LLC | $46.90 | 2021-2024 | Stratafix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $39.82 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $33.29 | 2023 | Arista Ah Flexitip |
| Astellas Pharma US INC | $31.04 | 2024 | Veozah |
| Eisai INC. | $24.81 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $22.78 | 2025 | Caldolor |
| Csl Behring | $13.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw E Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.